scispace - formally typeset
T

Tom Wolfe

Researcher at La Jolla Institute for Allergy and Immunology

Publications -  34
Citations -  3667

Tom Wolfe is an academic researcher from La Jolla Institute for Allergy and Immunology. The author has contributed to research in topics: Cytotoxic T cell & CTL*. The author has an hindex of 24, co-authored 34 publications receiving 3536 citations. Previous affiliations of Tom Wolfe include Novo Nordisk & Scripps Research Institute.

Papers
More filters
Journal ArticleDOI

CD4 + T cells are required for secondary expansion and memory in CD8 + T lymphocytes

TL;DR: The results demonstrate that T-cell help is ‘programmed’ into CD8+ T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.
Journal ArticleDOI

Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance.

TL;DR: Results indicate that an intrinsicproperty of the epitope (MHC binding affinity) and an intrinsic property of the host (naive precursor frequency) jointly dictate the immunodominance hierarchy of CD8+ T cell responses.
Journal ArticleDOI

Autoreactive CD4+ T Cells Protect from Autoimmune Diabetes via Bystander Suppression Using the IL-4/Stat6 Pathway

TL;DR: The generation and characterization of insulin B chain-specific "autoreactive" CD4+ regulatory T cells that locally suppress diabetogenic T cell responses against an unrelated self-antigen in a virus-induced model for type 1 diabetes are reported.
Journal ArticleDOI

Impaired Immunoproteasome Assembly and Immune Responses in PA28−/− Mice

TL;DR: It is shown that PA28 is necessary for immunoproteasome assembly and is required for efficient antigen processing, thus demonstrating the importance of PA28-mediated proteasome function in immune responses.
Journal ArticleDOI

CD40L Blockade Prevents Autoimmune Diabetes by Induction of Bitypic NK/DC Regulatory Cells

TL;DR: It is demonstrated that a single episode of CD40L blockade during development of the autoaggressive immune response completely prevented autoimmune disease in the RIP-LCMV mouse model for virally induced type 1 diabetes.